Sign in
4

Changes in Ownership

Adicet Bio, Inc. Filed Acc 0001209191-23-046100

Options or other derivatives

  • Chief Financial Officer acquired 536,708 shares (grant or award)
  • Chief Financial Officer returned 360,400 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Harvey Brian Nicholas Chief Financial Officer 2023-08-14 Returned to the company · Stock Option (Right to Buy) −90,000 0 D: show line 1 in the form
Harvey Brian Nicholas Chief Financial Officer 2023-08-14 Grant or award · Stock Option (Right to Buy) +90,000 90,000 D: show line 2 in the form
Harvey Brian Nicholas Chief Financial Officer 2023-08-14 Returned to the company · Stock Option (Right to Buy) −28,200 0 D: show line 3 in the form
Harvey Brian Nicholas Chief Financial Officer 2023-08-14 Grant or award · Stock Option (Right to Buy) +28,200 28,200 D: show line 4 in the form
Harvey Brian Nicholas Chief Financial Officer 2023-08-14 Returned to the company · Stock Option (Right to Buy) −125,000 0 D: show line 5 in the form
Harvey Brian Nicholas Chief Financial Officer 2023-08-14 Grant or award · Stock Option (Right to Buy) +125,000 125,000 D: show line 6 in the form
Harvey Brian Nicholas Chief Financial Officer 2023-08-14 Returned to the company · Stock Option (Right to Buy) −117,200 0 D: show line 7 in the form
Harvey Brian Nicholas Chief Financial Officer 2023-08-14 Grant or award · Stock Option (Right to Buy) +117,200 117,200 D: show line 8 in the form
Harvey Brian Nicholas Chief Financial Officer 2023-08-14 Grant or award · Stock Option (Right to Buy) +176,308 176,308 D: show line 9 in the form
Loading xslF345X05/doc4.xml…